MN santé (Nouveal et Maela) is a subsidiary of La Poste santé et Autonomie, playing a part in the careside offering through its expertise in medical telemonitoring. The company, a result of the merger of two historical players in medical telemonitoring and patient care orchestration (Nouveal and Maela), markets a digital platform dedicated to optimizing the medical follow-up of each patient to healthcare stakeholders. MN santé operates in the Health Care, Internet, and Mobile industries from its headquarters in France. The latest funding round, a Corporate Round for Nouveal, was led by La Poste on 27 September 2018.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Corporate Round - Nouveal e | Unknown | 1 | La Poste | 27 Sep 2018 |
Corporate Round - Nouveal e | €750.00K | 1 | Elior Group | 02 Oct 2017 |
Corporate Round - Nouveal e | €1.00M | 1 | Malakoff Mederic | 16 Dec 2016 |
No recent news or press coverage available for MN santé (Nouveal et Maela).